E-drug: Global framework for research on areas of market failure
-------------------------------------------------------------------------
This is a CPTech, MSF, Oxfam, HAI, TWN event. Jamie
http://www.cptech.org/events/geneva04292003/
International Meeting on a global framework for supporting health
research and development (R&D) in areas of market and public policy
failure.
29th April, 2003 - 08:30 to 18:00
The International Conference Centre of Geneva (CICG)
15, rue de Varembe
1211 Geneva, Switzerland
International Meeting on a global framework for supporting health
research and development (R&D) in areas of market and public policy
failure.
Provisional Agenda
Registration: from 08:30 to 09:00
09:00 to 09:15
Opening Comments
Sir John Sulston, Founding Director of the Wellcome Trust
Sanger Institute, Nobel Prize for Physiology or Medicine 2002, UK.
09:15 to 10:45 Panel 1
The Crisis in Health R&D: Where is market
driven R&D inadequate for public health needs?
Moderator: to be announced
R&D and drugs for Neglected Patients
Bernard P�coul, Director, Campaign for Access to Essential
Medicines, M�decins sans Fronti�res (MSF), Switzerland
Funding challenges for R&D in Africa
Monique Wasunna, Kenya Medical Research Institute, Kenya
(invited)
Better drugs to treat people living with AIDS
Bob Huff, GMHC Treatment Issues, Gay Men's Health Crisis, USA
AIDS Vaccine research, a global responsibility
Saul Walker, International AIDS Vaccine Initiative (IAVI), USA
Research on Drugs to Treat TB
Joelle Tanguy, Global TB Alliance, USA
Open Source Research
Tim Hubbard, Wellcome Trust Sanger Institute, UK
Existing framework for R&D
Janis Lazdins, World Health Organization
Programme for Research and Training in Tropical Diseases
(WHO-TDR), Switzerland
Discussion
10:45 to 11:00 Break
11:00 to 12:30 Panel 2
Current Global frameworks for Funding R&D
Moderator: Julian Fleet, UNAIDS, Switzerland
(invited)
Intellectual Property, R&D and Development
Charles Clift, DFID, Commission on Intellectual
Property Rights, UK
G8 and EC strategies to promote R&D
Lieve Fransen, European Commission, Belgium
(invited)
Identifying research gaps and addressing the
need for transparency of investment flows
Louis Currat, Global Forum for Health Research,
Switzerland
Present global mechanisms for R&D deliver
Jerry Reichman, Duke University School of Law, USA
Lessons from Public-Private Partnerships
Roy Widdus, Initiative on Public-Private
Partnerships for Health, Switzerland
Lessons from the WHO Framework Convention on
Tobacco Control
Derek Yach, World Health Organization, Switzerland
Discussion
12:30 to 14:00 Lunch
14:00 to 15:30 Panel 3
Developing a new framework for funding R&D
Moderator: Faizel Ismail, Mission of South
Africa, Switzerland
New Treaty Frameworks for Sharing Burden of
Funding R&D
James Love, Consumer Project on Technology, USA
Issues presented by WTO Agreements
Jayashree Watal, World Trade Organization,
Switzerland
Human Rights and R&D funding framework
Tenu Avafia, Legal Assistance Centre, Namibia
Technology Transfer Objectives of an R&D Treaty
Pedro Roffe, UNCTAD, Geneva
The World Health Report 2004 and the 2004
Mexico Ministerial Summit on Health R&D
Tikki Pang, World HealthOrganization,
Switzerland
Discussion
15:30 to 16:00 Break
16:00 to 18:00 Panel 4
How do we develop proactive policy in shaping R&D?
Moderator: Catherine Hodgkin, Royal Tropical Institute
The Netherlands
WHO View
Jonathan Quick, World Health Organization,
Switzerland
Industry View
Gill Samuels, Pfizer, UK
Developing Country role in shaping R&D policy
agenda
Sisule Fredrick Musungu, South Centre, Geneva
The World Health Assembly Agenda on
Intellectual Property, Innovation and Public
Health
Jorge Bermudez, Fiocruz, Brazil
NGO view
Philippa Saunders, Oxfam, UK
NGO view
Ellen �t Hoen, Campaign for Access to Essential
Medicines, M�decins sans Fronti�res, France
Next steps towards an international R&D
convention
Sir John Sulston, Founding Director of the
Wellcome Trust Sanger Institute, UK
Discussion
Closing of the meeting
For additional information, please contact:
CPTech: Ms Joy Spencer, joy.spencer@cptech.org
(+1.202.387.8030, fax +1.202.234.5176)
or
MSF: Ms Mai Do, mdo@paris.msf.org
(+ 33 1 4021 2825, fax + 33 1 4021 2962)
James Love, Director, Consumer Project on Technology
http://www.cptech.org, mailto:james.love@cptech.org
tel. +1.202.387.8030, mobile +1.202.361.3040
--
To send a message to E-Drug, write to: e-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@usa.healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug